A study on SARS-CoV-2 proteins for the development of COVID-19 drugs

By | June 16, 2021
The authors of the review have grouped the virus proteins into three categories, (a) host-entry, (b) self-acting, and (c) host-interacting. Additionally, individual SARS-CoV-2 proteins are evaluated to be either directly targeted by drugs or block virus-host interactions.